Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles

Luye Selects AstraZeneca to Market its Anti-Cholesterol Drug in China
Ironwood/AstraZeneca Approved to Market IBS-C Treatment in China
Innovent Doses First Patient in China Trial of "Don't Eat Me" Inhibitor
BeiGene Receives Breakthrough Status in US for BTK Inhibitor
Ascletis Acquires China Rights to Alphamab's PD-L1 for Hepatitis B
Upcoming event
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China